GSK Investigational Site
Gangwon-do 26426
0 studies enrolling now · 3 studies all time
What they study most
Herpes Zoster, Infections, Rotavirus, Pulmonary Disease, Chronic Obstructive, Rotavirus Vaccines
Studies at this site
- Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks — Completed
- A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022 — Completed
- Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2 — Completed